InnovAge Reports Strong Fiscal 2026 Results with Adjusted EBITDA Growth of 175%
InnovAge (INNV) reported strong financial results for fiscal year 2026, highlighting a significant increase in adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA), which rose by approximately 175% compared to the previous year. The company attributed this growth to its strategic focus on delivering high-quality care, expanding census numbers, strengthening operations, maintaining compliance, and translating past investments into improved financial performance. Despite these positive results, InnovAge noted that net income for the year was negatively impacted by one-time legal accruals. CEO Patrick Blair emphasized fiscal 2026 as a key milestone in the company's transformation journey and expressed confidence in its progress toward achieving long-term adjusted EBITDA margin targets of over 10%. The call also included forward-looking statements regarding future growth, challenges such as PACE reimbursement rate reductions, legal proceedings, and macroeconomic factors. The earnings report was accompanied by a detailed transcript from the company's Q4 fiscal year-end conference call. CFO Benjamin Adams and COO Jen Browne were among those participating in the discussion.
Tickers: $INNV